White-matter connectivity and methylphenidate-induced changes in attentional performance according to α2A-adrenergic receptor gene polymorphisms in Korean children with attention-deficit hyperactivity disorder

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 25, Issue 3, 2013, Pages 222-228

  Park, Subin ^a   Hong, Soon Beom ^a   Kim, Jae Won ^a   Yang, Young Hui ^b   Park, Min Hyeon ^a   Kim, Boong Nyun ^a   Shin, Min Sup ^a   Yoo, Hee Jeong ^c   Cho, Soo Churl ^a  

^a Seoul National University   (South Korea)

^b Pusan National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; GENOMIC DNA; METHYLPHENIDATE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN MAPPING; CHILD; CHILD PSYCHIATRY; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ERROR; DISEASE SEVERITY; DRUG TOLERANCE; DSM-IV; ECHO PLANAR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL CORTEX; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERACTIVITY; IMAGING; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENTAL PERFORMANCE; MIDDLE FRONTAL GYRUS; NORTH KOREA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTCENTRAL GYRUS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RESPONSE TIME; SCHOOL CHILD; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; WHITE MATTER;

ADOLESCENT; ANISOTROPY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHYLPHENIDATE; NERVE FIBERS, MYELINATED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-2; REPUBLIC OF KOREA;

EID: 84883851208     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12050121     Document Type: Article

References (22)

1. Polanczyk G, de Lima MS, Horta BL, et al: The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164:942-948
2. Franke B, Neale BM, Faraone SV: Genome-wide association studies in ADHD. Hum Genet 2009; 126:13-50
3. Biederman J, Spencer T: Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999; 46:1234-1242
4. Pliszka SR, McCracken JT, Maas JW: Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996; 35:264-272
5. Arnsten AF: Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 2006; 31:2376-2383
6. Arnsten AF, Steere JC, Hunt RD: The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function: potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53:448-455
7. Greene CM, Bellgrove MA, Gill M, et al: Noradrenergic genotype predicts lapses in sustained attention. Neuropsychologia 2009; 47:591-594
8. Lario S, Calls J, Cases A, et al: MspI identifies a biallelic polymorphism in the promoter region of the alpha 2Aadrenergic receptor gene. Clin Genet 1997; 51:129-130
9. Hoehe MR, Berrettini WH, Lentes KU: Dra I identifies a twoallele DNA polymorphism in the human alpha 2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR). Nucleic Acids Res 1988; 16:9070
10. Doyle AE, Faraone SV, Seidman LJ, et al: Are endophenotypes based on measures of executive functions useful for moleculargenetic studies of ADHD? J Child Psychol Psychiatry 2005; 46:774-803
11. Durston S: Converging methods in studying attentiondeficit/ hyperactivity disorder: what can we learn from neuroimaging and genetics? Dev Psychopathol 2008; 20: 1133-1143
12. Kim BN, Kim JW, Kang H, et al: Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2010; 35:330-336
13. Cho SC, Kim JW, Kim BN, et al: Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:957-963
14. van Ewijk H, Heslenfeld DJ, Zwiers MP, et al: Diffusion tensor imaging in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev 2012; 36:1093-1106
15. Kim YS, Cheon KA, Kim BN, et al: The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K). Yonsei Med J 2004; 45:81-89
16. So YK, Noh JS, Kim YS, et al: The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 2002; 41:283-289
17. Greenberg LM, Waldman ID: Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry 1993; 34:1019-1030
18. Wilke M, Holland SK, Altaye M, et al: Template-O-Matic: a toolbox for creating customized pediatric templates. Neuroimage 2008; 41:903-913
19. Solé X, Guinó E, Valls J, et al: SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22:1928-1929
20. Barkley RA: Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997; 121:65-94
21. Arnsten AF, Dudley AG: Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoreceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention-deficit hyperactivity disorder. Behav Brain Funct 2005; 1:2
22. Berridge CW, Devilbiss DM, Andrzejewski ME, et al: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006; 60:1111-1120